Chikako Kondo
Osaka University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Chikako Kondo.
Journal of Biological Chemistry | 1996
Shojiro Isomoto; Chikako Kondo; Mitsuhiko Yamada; Shigeto Matsumoto; Omi Higashiguchi; Yoshiyuki Horio; Yuji Matsuzawa; Yoshihisa Kurachi
We have isolated a cDNA encoding a novel isoform of the sulfonylurea receptor from a mouse heart cDNA library. Coexpression of this isoform and BIR (Kir6.2) in a mammalian cell line elicited ATP-sensitive K+ (KATP) channel currents. The channel was effectively activated by both diazoxide and pinacidil, which is the feature of smooth muscle KATP channels. Sequence analysis indicated that this clone is a variant of cardiac type sulfonylurea receptor (SUR2). The 42 amino acid residues located in the carboxyl-terminal end of this novel sulfonylurea receptor is, however, divergent from that of SUR2 but highly homologous to that of the pancreatic one (SUR1). Therefore, this short part of the carboxyl terminus may be important for diazoxide activation of KATP channels. The reverse transcription-polymerase chain reaction analysis showed that mRNA of this clone was ubiquitously expressed in diverse tissues, including brain, heart, liver, urinary bladder, and skeletal muscle. These results suggest that this novel isoform of sulfonylurea receptor is a subunit reconstituting the smooth muscle KATP channel.
The Journal of Physiology | 1997
Mitsuhiko Yamada; Shojiro Isomoto; Shigeto Matsumoto; Chikako Kondo; Takashi Shindo; Yoshiyuki Horio; Yoshihisa Kurachi
1. We analysed the K+ channel composed of the sulphonylurea receptor 2B (SUR2B) and an inwardly rectifying K+ channel subunit Kir6.1 coexpressed in a mammalian cell line, HEK293T, with the patch clamp technique. 2. In the cell‐attached configuration, K+ channel openers (pinacidil and nicorandil) activated approximately 33 pS K+ channels (approximately 145 mM external K+), which were inhibited by the sulphonylurea glibenclamide. 3. Although SUR2B forms an ATP‐sensitive K+ channel with Kir6.2, whose amino acid sequence is approximately 70% homologous with that of Kir6.1, the K+ channel composed of SUR2B and Kir6.1 surprisingly did not spontaneously open on patch excision in the absence of intracellular ATP. 4. In inside‐out patches, uridine diphosphate and guanosine diphosphate induced channel activity, which was inhibited by glibenclamide but not ATP. Intracellular ATP on its own activated the channels. K+ channel openers and intracellular nucleotides synergistically activated the channel. 5. Therefore, the K+ channel composed of SUR2B and Kir6.1 is not a classical ATP‐sensitive K+ channel but closely resembles the nucleotide diphosphate‐dependent K+ channel in vascular smooth muscle cells.
The Journal of Physiology | 1998
Eisaku Satoh; Mitsuhiko Yamada; Chikako Kondo; Vez Pagara Repunte; Yoshiyuki Horio; Toshihiko Iijima; Yoshihisa Kurachi
1 We have examined the properties of intracellular nucleotide‐mediated gating of K+ channel constructs composed of the sulphonylurea receptor 2B and the inwardly rectifying K+ channel subunits Kir6.1 and Kir6.2 (SUR2B/Kir6.1 and SUR2B/Kir6.2 complex K+ channels) heterologously expressed in human embryonic kidney (HEK) 293T cells. In the cell‐attached form, both types of K+ channel were activated by pinacidil. 2 In inside‐out (IO) patches, the SUR2B/Kir6.2 channels opened spontaneously and were inhibited by intracellular ATP (ATPi). Pinacidil attenuated the ATPi‐mediated channel inhibition in a concentration‐dependent manner. In contrast, the SUR2B/Kir6.1 channels required intracellular nucleoside di‐ or tri‐, but not mono‐, phosphates for opening. The potency of adenine, guanine or uracil nucleotides to activate SUR2B/Kir6.1 channels was enhanced by pinacidil. 3 In the presence of pinacidil, adenine and guanine, but not uracil, nucleotides exhibited bell‐shaped concentration‐dependent activating effects on SUR2B/Kir6.1 channels. This was due to channel inhibition caused by adenine and guanine nucleotides, which was unaffected by pinacidil. 4 From power density spectrum analysis of SUR2B/Kir6.1 currents, channel activation could be described by the product of two gates, a nucleotide‐independent fast channel gate and a nucleotide‐dependent slow gate, which controlled the number of functional channels. Pinacidil specifically increased the potency of nucleotide action on the slow gate. 5 We conclude that Kir6.0 subunits play a crucial role in the nucleotide‐mediated gating of SUR/Kir6.0 complex K+ channels and may determine the molecular mode of pinacidil action.
FEBS Letters | 1996
Chikako Kondo; Shojiro Isomoto; Shigeto Matsumoto; Mitsuhiko Yamada; Yoshiyuki Horio; Shizuya Yamashita; Kaoru Takemura-Kameda; Yuji Matsuzawa; Yoshihisa Kurachi
We have identified from rat kidney a novel isoform of ROMK/Kir1.1, designated ROMK6/Kir1.1f. ROMK6 was nearly identical to ROMK1, but possessed an 122‐bp insertion in the 5′ region. Its deduced amino acid sequence was shorter by 19 amino acids than that of ROMK1 in the amino‐terminus. Unlike other previously reported ROMK isoforms, ROMK6 mRNA was ubiquitously expressed in various tissues, including kidney, brain, heart, liver, pancreas and skeletal muscle. Xenopus oocytes injected with ROMK6 cRNA expressed a Ba2+‐sensitive weakly inwardly rectifying K+ current. These results indicate that ROMK6 is a novel functional K+ channel and might be involved in K+ secretion in various tissues.
The Journal of Physiology | 1996
T Yamashita; Yoshiyuki Horio; Mitsuhiko Yamada; Naohiko Takahashi; Chikako Kondo; Yoshihisa Kurachi
1. A cloned inwardly rectifying K+ channel, IRK2, was expressed in a human cell line, human embryonic kidney (HEK) 293T. Its electrophysiological properties were examined using the patch clamp technique in the whole‐cell, cell‐attached and inside‐out patch configurations. 2. The cells transfected with IRK2 cDNA exhibited a K+ current which showed classical properties of inwardly rectifying K+ channels at both whole‐cell and single‐channel levels. 3. In the inside‐out patch configuration, intracellular Mg2+ (Mg2+i blocked the outward currents in a voltage‐dependent and virtually time‐independent manner. Mg2+i (1‐100 microM) caused a decrease in the unitary current amplitude of the IRK2 channel by inducing subconducting levels. 4. In the absence of Mg2+i, intracellular spermine blocked the outwardly flowing IRK2 currents in a voltage‐ and time‐dependent manner. Spermine (1‐100 nM) did not affect the unitary channel current amplitude but reduced the channel open probability. The spermine block showed a slower time and steeper voltage dependence than the Mg2+i++ block. 5. When both these blockers were present, Mg2+i apparently attenuated the inhibitory effect of spermine on the outwardly flowing IRK2 currents. This interaction was voltage and time dependent, and could be well explained by a model in which Mg2+i and spermine competitively bind to the channel with their individual first‐order kinetics. This competition would induce time‐dependent transits of the channel between the Mg2+i ‐and spermine‐blocked states via a single open state, thereby preserving a certain size of persistent outward currents at depolarized potentials.
Mammalian Genome | 1997
Shojiro Isomoto; Yoshiyuki Horio; Shigeto Matsumoto; Chikako Kondo; Mitsuhiko Yamada; Debra J. Gilbert; Neal G. Copeland; Nancy A. Jenkins; Yoshihisa Kurachi
Species:Mouse Locus name: methionine synthase or 5-methyltetrahydrofolatehomocysteine methyltransferase Locus symbol:Mtr Map position: proximal–D13Mit1–1.06 cM ± 1.06 SE– Mtr, D13Bir4, D13Bir6–1.06 ± 1.06–D13Abb1e–2.13 ± 1.49–D13Bir7–distal Method of mapping:Mtr was localized by RFLP analysis of 96 animals from an interspecific backcross panel ((C57BL/6JEi × SPRET/Ei)F1 × SPRET/Ei) provided by The Jackson Laboratory, Bar Harbor, Me. (BSS panel) [1]. Database deposit information: The data are available from the Mouse Genome Database, accession number MGD-JNUM-39061. Molecular reagents:A 1095-bp mouse cDNA was obtained by reverse transcription/PCR of mouse liver RNA, with degenerate oligonucleotides based on regions of homology within the methionine synthase sequences of lower organisms. The two primers (D1730 and D1733), as described by Leclerc et al. [2], were successful in amplifying both human and mouse cDNAs. The PCR products from both species were subcloned and sequenced; they showed 89% identity. The mouse cDNA was labeled by random priming and hybridized to Southern blots of EcoRI-digested mouse genomic DNA. Allele detection:Allele detection was performed by RFLP analysis of an EcoRI polymorphism. The C57BL/6J strain has alleles of approximately 13 kb, while theMus spretusstrain has alleles of approximately 9 kb and 4 kb. A constant band of approximately 0.5 kb was seen in both strains. Previously identified homologs: Human MTR has been mapped to chromosomal band 1q43 by fluorescence in situ hybridization [2–4]. Discussion: Methionine synthase (EC 2.1.1.13, 5-methyltetrahydrofolate-homocysteine methyltransferase) catalyzes homocysteine remethylation to methionine, with 5-methyltetrahydrofolate as the methyl donor and methylcobalamin as a cofactor. Nutritional deficiencies and genetic defects in homocysteine metabolism result in varying degrees of hyperhomocysteinemia. Dramatic elevations in plasma and urinary homocysteine levels are associated with the inborn error of metabolism, homocystinuria. Consequent to the recent isolation of the human cDNA for methionine synthase [2–4], two groups of investigators have identified mutations in methionine synthase in homocystinuric patients [2, 5]. Mild elevations in plasma homocysteine are thought to be a risk factor for both vascular disease and neural tube defects [6–8]. A genetic variant in methylenetetrahydrofolate reductase (MTHFR), the enzyme that synthesizes 5-methyltetrahydrofolate for the methioninesynthase reaction, is the most common genetic determinant of hyperhomocysteinemia identified thus far [9]. Mild defects in the methionine synthase reaction are also potential candidates for hyperhomocysteinemia and the associated multifactorial diseases. A common variant has been reported for the human methionine synthase gene, but its physiologic consequences have not yet been determined [2, 4]. The mapping of the human MTR gene to 1q43 and of the mouse gene to proximal Chromosome (Chr) 13 is consistent with previous findings of human/mouse homologies between these 2 chromosomal regions; the human and mouse nidogen genes have been mapped to 1q43 and proximal Chr 13, respectively [10]. Several genes have already been implicated in neural tube defects in mice [11]. Studies involving the mouse methionine synthase gene will be useful in assessing the role of this important enzyme in the development of birth defects and/or vascular disease.
Current Topics in Membranes | 1999
Mitsuhiko Yamada; Eisaku Satoh; Chikako Kondo; Vez Pagara Repunte; Yoshihisa Kurachi
Publisher Summary This chapter reviews the progress in the molecular dissection of cardiovascular adenosine triphosphate (ATP)-sensitive potassium (K ATP ) channels and shows that the apparent differences between cardiac K ATP and vascular nucleoside diphosphates potassium (K NDP ) channels can be explained in terms of different combinations of subunits with similar molecular structures. Molecular dissection of inwardly rectifying potassium (Kir) channels and sulfonylurea receptors (SURs) has identified molecular structures of K ATP channels in the cardiovascular system. Further understanding at the molecular level of the K ATP channels in the cardiovascular system may enable to clarify the roles of these channels in cardiovascular physiology and pathophysiology that may allow development of strategies and pharmacological agents to treat various cardiovascular diseases.
Japanese Journal of Physiology | 1997
Shojiro Isomoto; Chikako Kondo; Yoshihisa Kurachi
Pflügers Archiv: European Journal of Physiology | 1998
Yuji Okuyama; Mitsuhiko Yamada; Chikako Kondo; Eisaku Satoh; Shojiro Isomoto; Takashi Shindo; Yoshiyuki Horio; Masafumi Kitakaze; Masatsugu Hori; Yoshihisa Kurachi
Biochemical and Biophysical Research Communications | 1996
Shojiro Isomoto; Chikako Kondo; Naohiko Takahashi; Shigeto Matsumoto; Mitsuhiko Yamada; Toru Takumi; Yoshiyuki Horio; Yoshihisa Kurachi